Saturday 17 October 2026
Export ALC’s income statement to Excel — free account
Alcon
ALC Healthcare Medical Instruments & Supplies
Alcon’s revenue for fiscal 2025 (year ended December 2025) was $10.4 billion, up 4.94% from fiscal 2024. In the quarter to June 2026, revenue grew 8.74%, EPS fell 100.0%, free cash flow was flat and total debt was flat, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.
66.18
0.40
−0.60%
Follow ALC
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
7 | 6 | 6 | 5 |
+8 more TTM periods Free account |
| 2.94% | 3.71% | 4.50% | 4.82% | ||
| 2.06% | 2.62% | 3.17% | 3.38% | ||
ROIC |
2.38% | 2.94% | 3.38% | 3.56% | |
Return on Tangible Assets |
7.84% | 9.78% | 11.99% | 13.02% | |
Average Days of Receivables |
70.57 | 68.99 | 68.85 | 69.49 | |
Free Cash Flow per Share |
3.28 | 3.28 | 3.27 | 2.81 | |
Free Cash Flow |
1,594.00 | 1,596.00 | 1,613.00 | 1,385.00 | |
Capital Expenditures |
(716.00) | (709.00) | (658.00) | (687.00) | |
| Other line items | |||||
Cash ROIC |
5.74% | 5.59% | 5.68% | 4.89% | |
Accounts Receivable Turnover |
5.28 | 5.50 | 5.59 | 5.50 | |
Accounts Payable Turnover |
5.03 | 5.39 | 5.48 | 5.24 | |
Inventory Turnover |
1.91 | 1.99 | 2.00 | 1.90 | |
Average Days of Payables |
75.38 | 70.66 | 72.59 | 71.47 | |
Days of Inventory on Hand |
195.47 | 187.46 | 187.44 | 194.28 | |
Tax Rate |
(0.13) | (0.17) | (0.16) | (0.16) | |
Research and Development Expense of Revenue |
13.18% | 9.53% | 9.52% | 9.32% | |
Selling, General and Administrative Expense of Revenue |
33.26% | 33.08% | 33.16% | 32.89% | |
Share Based Compensation of Revenue |
1.58% | 1.58% | 1.56% | 1.51% | |
Interest Coverage |
4.54 | 5.72 | 6.67 | 7.25 | |
Operating CF/Net income |
3.59 | 2.81 | 2.32 | 1.98 | |
Depreciation/Fixed assets |
0.38 | 0.28 | 0.25 | 0.25 | |
Capex/Depreciation |
(0.40) | (0.52) | (0.55) | (0.59) | |
Revenue per Share |
22.32 | 21.83 | 21.09 | 20.65 | |
Operating CF per Share |
4.75 | 4.73 | 4.60 | 4.20 | |
Capex per Share |
(1.47) | (1.46) | (1.33) | (1.39) | |
Capex to Sales |
0.07 | 0.07 | 0.06 | 0.07 |
Columns are period end dates